Share: Facebook Twitter LinkedIn
Activity Provided By:


Adaptive Learning to Improve Individualized Management of Type 2 Diabetes (T2D)

Access Activity

Overview / Abstract:

As a primary care provider, you play a critical role in the management of patients with type 2 diabetes. ACHL AdaptED® offers a unique experience designed to meet the needs of busy clinicians seeking to enhance their expertise in this area. Our adaptive learning platform allows you to tailor your educational experience to match your specific learning goals and knowledge gaps. This activity has you covered whether you're looking to deepen your understanding of the latest treatment options, improve your ability to manage comorbidities, or simply stay up-to-date on the latest research.

Featuring expert faculty with extensive experience in managing type 2 diabetes, the program delivers practical insights and strategies you can apply in your practice immediately. Don't miss this opportunity to take your skills to the next level and provide the best possible care for your patients. Access the ACHL AdaptED® platform today.


May 31, 2024


Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME



Credits / Hours

of 1.25 AMA PRA Category 1 Credit(s)



Presenters / Authors / Faculty

Kathleen Dungan, MD
Professor of Internal Medicine
Division of Endocrinology, Diabetes & Metabolism
The Ohio State University
Columbus, OH

Jennifer B. Green, MD
Professor of Medicine Division of Endocrinology, Metabolism and Nutrition
Duke Clinical Research Institute
Duke University School of Medicine
Durham, NC

Sponsors / Supporters / Grant Providers

Sponsored by the Academy for Continued Healthcare Learning (ACHL).
This activity is supported by an educational grant from Lilly.

Keywords / Search Terms

ACHL CME, CE, Lilly, Adaptive, type 2 diabetes, T2D, diabetes, T2DM, weight loss, weight, obesity, incretin, treatment intensification, glycemic control, glycemic, Kathleen Dungan, Jennifer Green, internal medicine, endocrinology, primary care, GLP-1 receptor agonist, GLP-1, cardiometabolic, dual GLP-1/GIP receptor agonists, HbA1c, incretin-based therapies, social determinants of health, SDOH, comorbidities Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map